Oxford Biomedica plc (OTCMKTS:OXBDF - Get Free Report)'s share price traded up 18.7% during trading on Thursday . The stock traded as high as $4.66 and last traded at $4.66. 550 shares traded hands during trading, a decline of 96% from the average session volume of 12,757 shares. The stock had previously closed at $3.93.
Oxford Biomedica Stock Performance
The company has a current ratio of 2.35, a quick ratio of 2.07 and a debt-to-equity ratio of 1.48. The stock has a fifty day moving average price of $3.80 and a two-hundred day moving average price of $4.51.
Oxford Biomedica Company Profile
(
Get Free Report)
Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.
Read More
Before you consider Oxford Biomedica, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oxford Biomedica wasn't on the list.
While Oxford Biomedica currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
